gl 331 has been researched along with bevirimat in 1 studies
| Studies (gl 331) | Trials (gl 331) | Recent Studies (post-2010) (gl 331) | Studies (bevirimat) | Trials (bevirimat) | Recent Studies (post-2010) (bevirimat) |
|---|---|---|---|---|---|
| 28 | 1 | 4 | 110 | 5 | 42 |
| Protein | Taxonomy | gl 331 (IC50) | bevirimat (IC50) |
|---|---|---|---|
| Gag-Pol polyprotein | HIV-1 M:B_HXB2R | 0.552 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, KH | 1 |
1 review(s) available for gl 331 and bevirimat
| Article | Year |
|---|---|
Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach.
Topics: Anti-HIV Agents; Biological Factors; Drug Design; Molecular Structure; Pharmaceutical Preparations; Plants, Medicinal | 2010 |